Consumer Health, Ninth Edition
References for Chapter 16
Cancer

  1. Brown HG. A final challenge. In Barrett S, Cassileth BR, editors. Dubious Cancer Treatment. Tampa, 1990, American Cancer Society, Florida Division.
  2. Cancer Facts & Figures 2011. Atlanta, 2011, American Cancer Society.
  3. Siegel R and others. Cancer Statistics, 2011. CA—A Cancer Journal for Clinicians 61:212-236, 2011.
  4. Meister K and others. Cigarettes: What the Warning Label Doesn’t Tell You. New York, 2003, American Council on Science and Health.
  5. Meister K and others. America’s War on Carcinogens. New York, 2004, American Council on Science and Health.
  6. U.S. Surgeon General issues new national health advisory on radon. U.S. Department of Health & Human Services news release, Jan 13, 2005.
  7. Krishnan SS. The HPV Vaccine Controversy: Sex, Cancer, God, and Politics: A Guide for Parents, Women, Men, and Teenagers.
  8. Westport, CT, Praeger Publishers, 2008.
  9. Heath CW Jr. Electromagnetic field exposure and cancer: A review of epidemiologic evidence. CA—A Cancer Journal for Clinicians 46:29-44, 1996.
  10. Leikind B. Do cell phones cause cancer? Skeptic Magazine 15: 30-34, 2010.
  11. Estabrook RW and others. Carcinogens and Anticarcinogens in the Human Diet. Washington, D.C., 1996, National Academy Press.
  12. Artificial sweeteners and cancer. NCI Fact sheet, Aug 5, 2009.
  13. Hardman AE. Physical activity and cancer risk. Proceedings of the Nutrition Society 60:107-113, 2001.
  14. Tumor grade: Questions and answers. National Cancer Institute fact sheet, May 19, 2004.
  15. Staging: Questions and answers. National Cancer Institute fact sheet, Jan 6, 2004.
  16. Fishman J and others. Cancer and the media: How does the news report on treatment and outcomes? Archives of Internal Medicine 170:515-518, 2010.
  17. Goozner M. Covering cancer: Comment on “Cancer and the Media.” Archives of Internal Medicine 170:518-520, 2010.
  18. Shaving chemotherapy: Killing patients with kindness. Medical World News, pp 24-25, April 28, 1986.
  19. Biological therapies for cancer. NCI Fact Sheet. National Cancer Institute fact sheet, June 13, 2006.
  20. Taking part in cancer treatment research studies. National Cancer Institute. Revised Sept 2011.
  21. Delaney P. Understanding clinical trials from the patient’s perspective. Coping, May/June 1997.
  22. NAS Committee on Diet, Nutrition, and Cancer. Diet, Nutrition, and Cancer. Washington, D.C., 1982, National Academy Press.
  23. Kushi LH and others. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA—A Cancer Journal for Clinicians 56:254-281, 2006. [2012 update]
  24. Weingarten MAMA and others. Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD003548. DOI: 10.1002/14651858.CD003548.pub4.
  25. Kritchevsky D. Diet and cancer. CA—A Cancer Journal for Clinicians 41:328-333, 1991.
  26. Fuchs CS and others. Dietary fiber and the risk of colorectal cancer and adenoma in women. New England Journal of Medicine 340:169-176, 1999.
  27. Asano TK, McLeod RS. Dietary fibre for the prevention of colorectal adenomas and carcinomas. Cochrane Database of Systematic Reviews 2002, Issue 2. Art. No.: CD003430. DOI: 10.1002/14651858.CD003430.
  28. Tsubono Y and others. Green tea and the risk of gastric cancer in Japan. New England Journal of Medicine 344:632-626, 2001.
  29. Sano T, Sasako M. Green tea and gastric cancer. New England Journal of Medicine 344:675, 2001.
  30. Brigden ML. Unorthodox therapy and your cancer patient. Postgraduate Medicine 81:271-280, 1987.
  31. Cassileth BR and others. Contemporary unorthodox treatments in cancer medicine. Annals of Internal Medicine 101:105-112, 1984.
  32. American Cancer Society. Questionable methods of cancer management. New York, 1992, The Society.
  33. Young JH. Laetrile in historical perspective. In Merkle GE, Petersen JC, editors. Politics, Science, and Cancer: The Laetrile Phenomenon. Boulder, Colo., 1980, Westview Press.
  34. Wilson B. The rise and fall of Laetrile. Quackwatch Web site, Feb 17, 2004.
  35. American Cancer Society. Unproven methods of cancer management: Laetrile. CA—A Cancer Journal for Clinicians 1:187-192, 1991.
  36. Moertel C and others. A clinical trial of amygdalin (Laetrile) in the treatment of human cancer. New England Journal of Medicine 306:201-206, 1982.
  37. Milazzo S and others. Laetrile treatment for cancers. Cochrane Database of Systematic Reviews 2011, Issue 11. Art. No.: CD005476. DOI: 10.1002/14651858.CD005476.pub3.
  38. Green S. Immunoaugmentative therapy. An unproven cancer treatment. JAMA 270:1719-1723, 1993.
  39. Questionable methods of cancer management: Immuno-augmentative therapy (IAT). CA—A Cancer Journal for Clinicians 41:357-363, 1991.
  40. Centers for Disease Control and Prevention. Isolation of human T-lymphotropic virus type III/lymphadenopathy-associated virus from serum proteins given to cancer patients -- Bahamas. Morbidity and Mortality Weekly Report 34:489-491, 1985.
  41. Mathews J. Media feeds frenzy over shark cartilage as cancer treatment. Journal of the National Cancer Institute 85:1190-1191, 1993.
  42. U.S. District Judge issues permanent injunction against Lane Labs-USA, Inc. and orders firm to refund money to purchasers of illegally marketed unapproved drugs. FDA news release, July 13, 2004.
  43. Loprinzi CL and others. Evaluation of shark cartilage in patients with advanced cancer. Cancer 104(1), July 1, 2005.
  44. Congress, Office of Technology Assessment. Unconventional Cancer Treatments, OTA-H-405. Washington, D.C., 1990, U.S. Government Printing Office.
  45. Barrett S. The bizarre claims of Hulda Clark. Quackwatch Web site, Nov 9, 2004.
  46. Tyler VE. Pau d’arco. Nutrition Forum 2:8, 1985.
  47. American Cancer Society. Unproven methods of cancer management: Macrobiotic diets for the treatment of cancer. CA—A Cancer Journal for Clinicians 39:248-251, 1989.
  48. Lowell J. The Gerson clinic. Nutrition Forum 3:9-12, 1986.
  49. Austin S, Dale EB, DeKadt S. Long-term follow-up of cancer patients using Contreras, Hoxsey and Gerson therapies. Journal of Naturopathic Medicine 5(1):74-76, 1994.
  50. Green S. A critique of the rationale for cancer treatment with coffee enemas and diet. JAMA 268:3224-3227, 1992.
  51. American Cancer Society. Questionable methods of cancer management: Questionable “nutritional” therapies in the treatment of cancer. CA—A Cancer Journal for Clinicians 43:309-319, 1993.
  52. Brooks SP. Some notes on cancer and the immune system. Cancer Treatment Watch Web site, March 30, 2010.
  53. Working group on unproven methods in oncology. Iscador. File No. 10E, Bern, 1984, Swiss Cancer League..
  54. Steuer-Vogt MK and others. The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: A randomised controlled clinical trial. European Journal of Cancer 37:23-31, 2001.
  55. Goebell PJ. Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: A randomized phase II trial. Journal of Urology 168:72-65, 2002.
  56. American Cancer Society. Questionable methods of cancer management: Hydrogen peroxide and other “hyperoxygenation” therapies. CA—A Cancer Journal for Clinicians 43:47-55, 1993.
  57. Green S. Oxygenation Therapy: Unproven treatments for cancer and AIDS. Scientific Review of Alternative Medicine 2(1):6-12, 1998.
  58. Gelb L. Unproven cancer treatments: Help or hoax? FDA Consumer 26(2):10-15, 1992.
  59. Segal M. Court says cancel the CanCell. FDA Consumer 27(4):40-41, 1993.
  60. National Cancer Institute studies of hydrazine sulfate. NIH news release, Aug 19, 1997.
  61. London WM. The Penthouse politics of cancer: The promotion of hydrazine sulfate and a medical conspiracy theory. Priorities for Health 10(4):7-13, 34-35, 1998.
  62. Blackstein ME, Sergsagel DE. Report to the Ontario Ministry of Health on the treatment of cancer patients with antineoplastons and the Burzynski clinic in Houston, Texas. Undated, circa 1983.
  63. Green S. “Antineoplastons”: An unproved cancer therapy. JAMA 267:2924-2928, 1992.
  64. Texas Attorney General’s Office. Morales halts use of unapproved cancer treatment. News release, Feb 10, 1998.
  65. The antineoplaston anomaly: How a drug was used for decades in thousands of patients, with no safety, efficacy data. Cancer Letter, Sept 25, 1998.
  66. Administration of the Special Access Programme with respect to 714-X: Decision of the Federal Court, Trial Division of July 28, 2006. Health Canada notice, Oct 2, 2006.
  67. State health director warns consumers about prescription drugs in herbal products. California Department of Health Services news release, Feb 7, 2002.
  68. Cancer “cure” challenged. Consumer Reports on Health 2:21-22, 1990.
  69. Mirkin G. Acid/alkaline theory of disease is nonsense. Quackwatch Web site, Jan 11, 2009.
  70. American Cancer Society. Unproven methods of cancer management: Livingston-Wheeler therapy. CA—A Cancer Journal for Clinicians 40:103-107, 1990.
  71. Cassileth BR and others. Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy. New England Journal of Medicine 324:1180-1185, 1991.
  72. American Cancer Society. Unproven methods of cancer management: Fresh cell therapy. CA—A Cancer Journal for Clinicians 41:126-128, 1991.
  73. American Cancer Society. Unproven methods of cancer management: Greek Cancer Cure. CA—A Cancer Journal for Clinicians 40:368-371, 1990.
  74. Baratz RS. Why you should stay away from insulin potentiation therapy (IPT). Quackwatch Web site, March 10, 2007.
  75. American Cancer Society. Questionable methods of cancer management: Electronic devices. CA—A Cancer Journal for Clinicians 44:115-127, 1994.
  76. Barnes C. Testimony before the Subcommittee on Health and Long-Term Care of the U.S. House of Representatives Select Committee on Aging. In Pepper C and others. Quackery: A $10 Billion Scandal. Washington, D.C., 1984, U.S. Government Printing Office.
  77. Gellert G, Maxwell RM, Siegel BS. Survival of breast cancer patients receiving adjunctive psychosocial support therapy: A 10-year follow-up study. Journal of Clinical Oncology 11:66-69, 1993.
  78. Friedlander ER. Mental imagery. In Barrett S, Cassileth BR, editors. Dubious Cancer Treatment. Tampa, 1990, American Cancer Society, Florida Division.
  79. American Cancer Society. Unproven methods of cancer management: O. Carl Simonton, MD. CA—A Cancer Journal for Clinicians 32:59, 1982.
  80. Petticrew M and others. Influence of psychological coping on survival and recurrence in people with cancer: Systematic review. British Medical Journal 325:1066-1075, 2002.
  81. Coyne JC and others. Psychotherapy and survival in cancer: The conflict between hope and evidence. Psychological Bulletin 133:367-394, 2007.
  82. Stefanek ME and others. Finding what is not there: Unwarranted claims of an effect of psychosocial intervention on recurrence and survival. Cancer 115:5612-5616, 2009.
  83. American Cancer Society. Kelley malignancy index and ecology therapy. In Unproven Methods of Cancer Management. New York, 1971, The Society.
  84. Chabot JA and others. Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer. Journal of Clinical Oncology 28:1979-1981, 2010.
  85. South J. The Manner seminar. Nutrition Forum 5:61-67, 1988.
  86. Cassileth BR. Quoted in Nourse AE. Quack cancer cures. Good Housekeeping, pp 58-69, Sept 1983.
  87. American Cancer Society. Unproven methods of cancer management: National Health Federation. CA—A Cancer Journal for Clinicians 41:61-64, 1991.
  88. Schmidt K, Ernst E. Assessing websites on complementary and alternative medicine for cancer. Annals of Oncology 15:733-742, 2004.
  89. Barrett S. Stay Away from Dr. Lorraine Day. Quackwatch Web site, Feb 7, 2010.
  90. Barrett S. NAD concludes that Lorraine Day infomercial is misleading. Infomercial Watch Web site, Dec 13, 2004.
  91. Weiss J. Critics say cancer ads deceptive. Dallas Morning News, June 21, 1992, pp 1A, 26A.
  92. Companies that purport to successfully treat cancer agree to settle FTC charges over their claims. FTC News, March 13, 1996.
  93. Ades T and others. American Cancer Society Complete Guide to Complementary & Alternative Cancer Therapies. Atlanta, 2009, American Cancer Society.
  94. Janssen WF. Cancer quackery: Past and present. FDA Consumer 11(6):27-32, 1977.
  95. Fojo T, Grady C. How much is life worth: Cetuximab, non-small cell lung cancer, and the $440 billion question. Journal of the National Cancer Institute 101:1044-1048, 2009.

This page was revised on December 8, 2012.